Literature DB >> 536262

Response of a rat brain tumor to fractionated therapy with low doses of BCNU and irradiation.

K T Wheeler, K Kaufman, M Feldstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 536262     DOI: 10.1016/0360-3016(79)90770-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  7 in total

1.  Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study.

Authors:  B D Ross; Y J Zhao; E R Neal; L D Stegman; M Ercolani; O Ben-Yoseph; T L Chenevert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

2.  Complications after combination of chemotherapy and radiation for malignant brain tumours.

Authors:  R Dietz; L Burger; K Schimrigk; K H Merkel
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

3.  DNA repair kinetics in irradiated undifferentiated and terminally differentiated cells.

Authors:  K T Wheeler; J V Wierowski
Journal:  Radiat Environ Biophys       Date:  1983       Impact factor: 1.925

4.  The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.

Authors:  H Brem; M G Ewend; S Piantadosi; J Greenhoot; P C Burger; M Sisti
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

5.  Is cell survival a determinant of the in situ response of 9L tumours?

Authors:  K T Wheeler; C A Wallen
Journal:  Br J Cancer Suppl       Date:  1980-04

6.  The 9L rat brain tumor model for pre-clinical investigation of radiation-chemotherapy interactions.

Authors:  B F Kimler
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.

Authors:  K T Wheeler; C A Wallen; K L Wolf; D W Siemann
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.